Suchergebnisse - "Galluzzo, Marco"

PubPharm (9)

1

Secukinumab for the treatment of palmoplantar psoriasis : a 2-year, multicenter, real-life observational study

enthalten in: Expert opinion on biological therapy | 2022

von Galluzzo, M. | Talamonti, M. | Atzori, L. | +12

2

Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis : Results from the SUPREME Study

enthalten in: Acta dermato-venereologica | 2021

von Costanzo, A. | Russo, F. | Galluzzo, M. | +30

3

Impact of secukinumab on patient-reported outcomes in moderate to severe plaque psoriasis : a review of clinical studies

enthalten in: Expert opinion on biological therapy | 2021

von Galluzzo, M. | Talamonti, M. | Manfreda, V. | +5

4

Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era

enthalten in: Expert opinion on biological therapy | 2020

von Galluzzo, M. | Tofani, L. | Bianchi, L. | +1

5

In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis

enthalten in: Expert opinion on biological therapy | 2020

von Galluzzo, M. | D'Adamio, S. | Silvaggio, D. | +3

6

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis : results from extension phase of the SUPREME study

enthalten in: The British journal of dermatology | 2019

von Papini, M. | Cusano, F. | Romanelli, M. | +58

7

Biologic therapy for acrodermatitis continua of Hallopeau : Successful treatment with secukinumab and review of the literature

enthalten in: Dermatologic therapy | 2019

von Galluzzo, M. | D'Adamio, S. | Teoli, M. | +2

8

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis : SUPREME study

enthalten in: The British journal of dermatology | 2018

von Costanzo, A. | Bianchi, L. | Flori, M. | +53

9

Secukinumab in moderate-to-severe plaque psoriasis : a multi-center, retrospective, real-life study up to 52 weeks observation

enthalten in: Expert opinion on biological therapy | 2018

von Galluzzo, M. | Talamonti, M. | De Simone, C. | +7

1
[1]